Compare GRFS & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | ESNT |
|---|---|---|
| Founded | 1940 | 2008 |
| Country | Spain | Bermuda |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.9B |
| IPO Year | N/A | 2013 |
| Metric | GRFS | ESNT |
|---|---|---|
| Price | $7.84 | $58.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $10.15 | ★ $67.86 |
| AVG Volume (30 Days) | 682.6K | ★ 763.2K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | 1.79% | ★ 2.43% |
| EPS Growth | N/A | ★ 0.73 |
| EPS | N/A | ★ 6.90 |
| Revenue | N/A | ★ $1,260,935,000.00 |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $6.50 | $3.27 |
| P/E Ratio | $18.67 | ★ $8.36 |
| Revenue Growth | N/A | ★ 1.45 |
| 52 Week Low | $6.19 | $51.61 |
| 52 Week High | $11.14 | $67.09 |
| Indicator | GRFS | ESNT |
|---|---|---|
| Relative Strength Index (RSI) | 27.72 | 35.84 |
| Support Level | $7.64 | $56.90 |
| Resistance Level | $9.11 | $61.99 |
| Average True Range (ATR) | 0.29 | 1.07 |
| MACD | -0.12 | -0.23 |
| Stochastic Oscillator | 2.99 | 24.72 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.